CXCL16 and neoplasm: Interestingly, CXCL16 NAb injection significantly decreased the overall percentage of tumor-infiltrated CXCL16+ CD45.1+ cells in MCT-treated tumors (Fig. 4d and Supplementary Fig. 4c).